{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:19:25Z","timestamp":1793085565307,"version":"4.5.0"},"reference-count":61,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Benzodiazepine receptor agonists (BZRA), which include benzodiazepines and z-drugs, are commonly prescribed for insomnia and anxiety in older adults, and used often long term. Yet, the risk\u2013benefit ratio of BZRA use in older adults may be unfavorable and many recommendations suggest avoidance or a maximal treatment duration of 4\u2009weeks. The aim of this study was to describe trends of BZRA use in older adults and associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using data from the Belgian Health Interview Survey in 2004 ( n\u2009=\u20093594), 2008 ( n\u2009=\u20092917), and 2013 ( n\u2009=\u20092048), prevalence standardized for age, sex, and region were calculated to assess trends of BZRA use in people \u2a7e65\u2009years. Analysis of associated factors to BZRA use was performed using a sub-sample of 2013 data for which variables assessing sleeping disorder and anxiety disorder were not missing ( n\u2009=\u20091286). Variables from seven main topics were explored using multivariate logistic regression: socio-demographic factors, geriatric factors, comorbidities, subjective health and mental health indicators, social health indicators, medication use and healthcare services use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, standardized prevalence of BZRA use decreased significantly between 2004 and 2013 [22% to 18%, prevalence difference (95% confidence interval, CI): \u22124.0% (\u22126.8; \u22121.3)]. Factors associated with BZRA use in multivariable analysis included female gender [adjusted odds ratio (aOR) (95%CI) : 1.62 (1.14; 2.29)], poor mental health [aOR (95%CI): 1.73 (1.13\u20132.63)] a fall in the past 12\u2009months [aOR (95%CI): 1.52 (1.02; 2.26), reporting a sleeping disorder [aOR (95%CI): 1.92 (1.35; 2.72)], polypharmacy [aOR (95%CI): 2.51 (1.75; 3.60)], and trazodone use [aOR (95%CI): 4.05 (1.64; 10.21)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite an encouraging decline observed from 2004 to 2013, BZRA use remained highly prevalent in Belgian older adults. Promotion of alternatives to BZRA in treatment of sleeping problems need to be continued. Among BZRA older users, women, the oldest (\u2a7e85\u2009years) and high-risk subgroups should be targeted in deprescribing interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20451253211011874","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T02:12:06Z","timestamp":1621995126000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-0014","authenticated-orcid":false,"given":"Catherine","family":"P\u00e9tein","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Avenue Mounier, 72 bte B1.72.02, Brussels, 1200, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"},{"name":"Institute of Health and Society (IRSS), Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"bibr1-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317696454"},{"key":"bibr2-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003"},{"key":"bibr3-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"bibr4-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2017.04.002"},{"key":"bibr5-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730"},{"key":"bibr6-20451253211011874","first-page":"72","volume":"10","author":"Hogan DB","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"bibr7-20451253211011874","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-6-201003160-00008"},{"key":"bibr8-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.05.004"},{"key":"bibr9-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503509"},{"key":"bibr10-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)00051-6"},{"key":"bibr11-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"bibr12-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145"},{"key":"bibr13-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1080\/15622970802465807"},{"key":"bibr14-20451253211011874","unstructured":"Service Public F\u00e9d\u00e9ral Sant\u00e9 Publique S\u00e9curit\u00e9 de la cha\u00eene alimentaire et Environnement. Somnif\u00e8res et calmants, pensez d\u2019abord aux autres solutions, https:\/\/www.health.belgium.be\/fr\/sante\/prenez-soin-de-vous\/medication\/somniferes-et-calmants#article (2018, accessed 14 November 2018)."},{"key":"bibr15-20451253211011874","unstructured":"Van der Heyden J. Consommation de m\u00e9dicaments. In: Drieskens S, Gisle L, Van der Heyden J, et al. (\u00e9ds) Enqu\u00eate de sant\u00e9 2013, Rapport 3: utilisation des services de soins de sant\u00e9 et des services sociaux. Brussels: WIV-ISP, https:\/\/his.wiv-isp.be\/SitePages\/Reports.aspx (2015, accessed, 25 February 2020)."},{"key":"bibr16-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1188-z"},{"key":"bibr17-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16751"},{"key":"bibr18-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1017\/S104161021200169X"},{"key":"bibr19-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1950"},{"key":"bibr20-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100326"},{"key":"bibr21-20451253211011874","unstructured":"Scientific Institute of Public Health and OD Public Health and Surveillance. Health interview survey 2013 (data file and codebook) 2015, obtainable under condition from the Sciensano website: https:\/\/his.wiv-isp.be\/SitePages\/Acces_microdata.aspx."},{"key":"bibr22-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1186\/0778-7367-71-24"},{"key":"bibr23-20451253211011874","unstructured":"Charafeddine R, Demarest S, Drieskens S, et al. Health interview survey 2013: research protocol, https:\/\/his.wiv-isp.be\/Shared%20Documents\/Protocol2013.pdf (2013, accessed 25 June 2020)."},{"key":"bibr24-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-015-0095-7"},{"key":"bibr25-20451253211011874","unstructured":"Kumar M. dsr: Compute directly standardized rates, ratios and differences. R package version 0.2.2, https:\/\/CRAN.R-project.org\/package=dsr (2019, accessed 19 May 2020)."},{"key":"bibr26-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00093-6"},{"key":"bibr27-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"bibr28-20451253211011874","volume-title":"Manual of the general health questionnaire","author":"Goldberg DP","year":"1978"},{"key":"bibr29-20451253211011874","first-page":"217","volume-title":"The use of psychological testing for treatment planning and outcome assessment","author":"Derogatis LR","year":"1994"},{"key":"bibr30-20451253211011874","volume-title":"EUROHIS: developing common instruments for health surveys","author":"Meltzer H","year":"2003"},{"key":"bibr31-20451253211011874","unstructured":"Centre Belge d\u2019Information Pharmacoth\u00e9rapeutique. Formulaire de soins aux personnes \u00e2g\u00e9es: troubles anxieux g\u00e9n\u00e9ralis\u00e9s, https:\/\/farmaka.cbip.be\/fr\/formulaire-p-a\/166#main (2021, accessed 12 February 2021)."},{"key":"bibr32-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-012-0003-6"},{"key":"bibr33-20451253211011874","volume":"5","author":"Everitt H","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr34-20451253211011874","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, https:\/\/www.R-project.org\/ (2018, accessed 18 May 2020)."},{"key":"bibr35-20451253211011874","unstructured":"Barnier J, Briatte F, Larmarange J. questionr: Functions to make surveys processing easier, R package version 0.7.0, https:\/\/CRAN.R-project.org\/package=questionr (2018, accessed 18 May 2021)."},{"key":"bibr36-20451253211011874","unstructured":"Fox J, Weisberg S. An {R} companion to applied regression. 3rd ed. Thousand Oaks, CA: Sage, 2019. https:\/\/socialsciences.mcmaster.ca\/jfox\/Books\/Companion"},{"key":"bibr37-20451253211011874","unstructured":"Subhash RL, Keim JL, Solymos P. ResourceSelection: resource selection (probability) functions for use-availability data, R package version 0.3-5, https:\/\/CRAN.R-project.org\/package=ResourceSelection (2019, accessed 18 May 2021)."},{"key":"bibr38-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti623"},{"key":"bibr39-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031156"},{"key":"bibr40-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317743651"},{"key":"bibr41-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurger.2012.04.007"},{"key":"bibr42-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1080\/13607860410001669778"},{"key":"bibr43-20451253211011874","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20130076"},{"key":"bibr44-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02783-1"},{"key":"bibr45-20451253211011874","first-page":"964","volume":"56","author":"Siriwardena AN","year":"2006","journal-title":"Br J Gen Pract"},{"key":"bibr46-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228495"},{"key":"bibr47-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14379"},{"key":"bibr48-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016644466"},{"key":"bibr49-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.03015.x"},{"key":"bibr50-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4483"},{"key":"bibr51-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2189"},{"key":"bibr52-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161248"},{"key":"bibr53-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2257-8"},{"key":"bibr54-20451253211011874","volume":"19","author":"Seppala LJ","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"bibr55-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.16131"},{"key":"bibr56-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.2413"},{"key":"bibr57-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-016-0182-z"},{"key":"bibr58-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2104"},{"key":"bibr59-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1111\/add.14981"},{"key":"bibr60-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0544-4"},{"key":"bibr61-20451253211011874","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0019-8"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253211011874","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253211011874","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253211011874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:52:21Z","timestamp":1777593141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253211011874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":61,"alternative-id":["10.1177\/20451253211011874"],"URL":"https:\/\/doi.org\/10.1177\/20451253211011874","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"20451253211011874"}}